Lung Cancer Clinical Trial

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Summary

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. The purpose of this study is to determine if telisotuzumab vedotin works better than docetaxel and to assess how safe telisotuzumab vedotin is in adult participants with NSCLC who have previously been treated. Change in disease activity and adverse events will be assessed.

Telisotuzumab vedotin is an investigational drug being developed for the treatment of NSCLC. Study doctors put the participants in 1 of 2 groups, called treatment arms. Each group receives intravenous (IV) infusion of telisotuzumab vedotin or IV infusion of docetaxel. Approximately 698 adult participants with c-Met overexpressing NSCLC will be enrolled in the study in approximately 250 sites worldwide.

Participants will receive IV telisotuzumab vedotin every 2 weeks or docetaxel every 3 weeks until meeting study drug discontinuation criteria.

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participants must have c-Met overexpressing non-small cell lung cancer (NSCLC) as assessed by an AbbVie designated immunohistochemistry (IHC) laboratory.
Archival or fresh tumor material must be submitted for assessment of c-Met levels during the Pre-Screening period. Tumor material from the primary tumor site and/or metastatic sites are allowed.
A histologically documented non-squamous cell NSCLC that is locally advanced or metastatic.
A known epidermal growth factor receptor (EGFR) activating mutation status.
Actionable alterations in genes other than EGFR .
Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.
An Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1.

Have received no more than 1 line of prior systemic cytotoxic chemotherapy in the locally advanced or metastatic setting.

Neoadjuvant and adjuvant systemic cytotoxic chemotherapy will count as a prior line for eligibility purposes if progression occurred within 6 months of the end of therapy.

Have progressed on at least 1 line of prior therapy for locally advanced/metastatic NSCLC:

Participants WITHOUT an actionable gene alteration: must have progressed on (or be considered ineligible for) platinum-based chemotherapy and immune checkpoint inhibitor (as monotherapy or in combination with chemotherapy).

Participants WITH an actionable gene alteration for which immune checkpoint inhibitor therapy is not standard of care (e.g., anaplastic lymphoma kinase [ALK] translocation): must have progressed on (or be considered ineligible for) anti-cancer therapy targeting driver gene alterations and platinum-based chemotherapy.

Participants with actionable gene alterations for which immune checkpoint inhibitor is standard of care must have also progressed on (or be considered ineligible for) immune checkpoint inhibitor (as monotherapy or in combination with chemotherapy).
Must be considered appropriate for docetaxel therapy based on the assessment of the treating physician.

Participants with metastases to the central nervous system (CNS) are eligible only after definitive therapy (such as surgery or radiotherapy) is provided and:

There is no evidence of progression of CNS metastases at least 2 weeks after definitive therapy.
They are asymptomatic and off or on a stable or reducing dose of systemic steroids and/or anticonvulsants for at least 2 weeks prior to first dose of telisotuzumab vedotin.

Exclusion Criteria:

Participants with adenosquamous histology.
Actionable epidermal growth factor receptor (EGFR) activating mutations.
Participants who have received prior c-Met-targeted antibodies.
Participants who have received prior docetaxel therapy.

A history of other malignancies except:

Malignancy treated with curative intent and with no known active disease present for >=2 years before the first dose of study drug and felt to be at low risk for recurrence by investigator.
Adequately treated non-melanoma skin cancer or lentigo maligna without evidence of disease.
Adequately treated carcinoma in situ without current evidence of disease.
A history of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, or idiopathic pneumonitis, or evidence of active pneumonitis on screening chest computed tomography (CT) scan. A history of prior radiation pneumonitis in the radiation field (fibrosis) is permitted.
Unresolved clinically significant adverse event (AE) >= Grade 2 from prior anticancer therapy, except for alopecia or anemia.
Major surgery within 21 days prior to the first dose of telisotuzumab vedotin.
Clinically significant condition(s) as listed in the protocol.

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

698

Study ID:

NCT04928846

Recruitment Status:

Recruiting

Sponsor:

AbbVie

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 205 Locations for this study

See Locations Near You

The Oncology Institute of Hope and Innovation - DTLA /ID# 239774
Los Angeles California, 90015, United States
Eisenhower Medical Center /ID# 233189
Rancho Mirage California, 92270, United States
Ocala Oncology Florida Cancer Affiliates - Main /ID# 234228
Ocala Florida, 34474, United States
The Queens Medical Center /ID# 250633
Honolulu Hawaii, 96813, United States
Kaiser Permanente Moanalua Medical Center /ID# 238363
Honolulu Hawaii, 96819, United States
Edward-Elmhurst Cancer Center /ID# 238552
Elmhurst Illinois, 60126, United States
St. Joseph Mercy Hospital /ID# 232190
Ypsilanti Michigan, 48197, United States
Hulston Cancer Center /ID# 232226
Springfield Missouri, 65807, United States
Renown Medical Group - Oncology/Hematology /ID# 247942
Reno Nevada, 89502, United States
San Juan Oncology Associates /ID# 244387
Farmington New Mexico, 87401, United States
Maimonides Medical Center /ID# 240783
Brooklyn New York, 11219, United States
First Health of the Carolinas /ID# 241279
Pinehurst North Carolina, 28374, United States
Genesis Cancer Care Center /ID# 239190
Zanesville Ohio, 43701, United States
Avera Cancer Institute /ID# 239635
Sioux Falls South Dakota, 57105, United States
Centro Médico Austral /ID# 239860
Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires, 1019, Argentina
Instituto de Oncologia Angel H. Roffo /ID# 231499
Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires, 1417, Argentina
Cenit /Id# 239880
Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires, 1125, Argentina
Hospital Britanico de Buenos Aires /ID# 231495
Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires, 1280, Argentina
Cemic /Id# 231486
Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires, 1431, Argentina
Centro de Investigaciones Clinicas Clinica Viedma S.A. /ID# 232339
Viedma Rio Negro, 8500, Argentina
St George Private Hospital /ID# 247716
Kogarah New South Wales, 2217, Australia
Barwon Health /ID# 241920
Geelong Victoria, 3220, Australia
Austin Health /ID# 247507
Heidelberg Victoria, 3084, Australia
Ordensklinikum Linz GmbH Elisabethinen /ID# 240967
Linz Oberoesterreich, 4010, Austria
Klinikum Wels-Grieskirchen GmbH /ID# 249000
Wels Oberoesterreich, 4600, Austria
Medizinische Universitaet Innsbruck /ID# 240981
Innsbruck Tirol, 6020, Austria More Info
Site Coordinator
Contact
+43 512 504 80308
Landeskrankenhaus Feldkirch /ID# 250333
Feldkirch Vorarlberg, 6800, Austria
Medizinische Universitaet Wien /ID# 230615
Vienna Wien, 1090, Austria
Klinik Penzing /ID# 230700
Vienna Wien, 1140, Austria
Klinik Floridsdorf /ID# 230608
Vienna Wien, 1210, Austria
Landeskrankenhaus Salzburg-Universitätsklinikum der PMU (LKH) /ID# 232467
Salzburg , 5020, Austria
Universitair Ziekenhuis Antwerpen /ID# 239971
Edegem Antwerpen, 2650, Belgium
Grand Hopital de Charleroi /ID# 234178
Charleroi Hainaut, 6000, Belgium
AZ Klina /ID# 239853
Brasschaat , 2930, Belgium
Ensino e Terapia de Inovacao Clínica AMO - Etica /ID# 231604
Salvador Bahia, 41830, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre /ID# 233249
Porto Alegre Rio Grande Do Sul, 90020, Brazil
Fundacao Pio XII - Hospital de Cancer de Barretos /ID# 233247
Barretos Sao Paulo, 14784, Brazil
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) /ID# 231509
Rio de Janeiro , 20231, Brazil
Instituto D'or de Pesquisa e Ensino /ID# 233245
Rio de Janeiro , 22281, Brazil
Instituto de Ensino e Pesquisa Sao Lucas /ID# 247417
Sao Paulo , 01236, Brazil
Casa de Saúde Santa Marcelina /ID# 231605
Sao Paulo , 08270, Brazil
Complex Oncology Center - Burgas /ID# 240532
Burgas , 8000, Bulgaria
UMHAT Sofiamed /ID# 234108
Sofia , 1797, Bulgaria
UMHAT Sveta Marina /ID# 234112
Varna , 9010, Bulgaria
CISSS de la Monteregie /ID# 239081
Greenfield Park Quebec, J4V 2, Canada
Clinica Universidad Catolica del Maule /ID# 231294
Talca Maule, 34613, Chile
Icegclinic /Id# 231212
La Florida Region Metropolitana De Santiago, 82414, Chile
Sociedad Prosalud Montes y Orlandi /ID# 231154
Providencia Region Metropolitana Santiago, 75007, Chile
Fundacion Arturo Lopez Perez /ID# 231151
Providencia Region Metropolitana Santiago, 75009, Chile
Sociedad Oncovida /ID# 231152
Providencia Region Metropolitana Santiago, 75100, Chile
Anhui Chest Hospital /ID# 231899
Hefei Anhui, 23002, China
Peking Union Medical College Hospital /ID# 233175
Beijing Beijing, 10003, China
Beijing Cancer Hospital /ID# 231923
Beijing Beijing, 10014, China
Beijing Chest Hospital, Capital Medical University /ID# 232202
Beijing Beijing, 10114, China
Fujian Provincial Cancer Hospital /ID# 243134
Fuzhou Fujian, 35001, China
The First Affiliated Hospital of Xiamen University /ID# 242381
Xiamen Fujian, 36100, China
The First Affiliated Hospital of Guangzhou Medical University /ID# 238591
Guangzhou Guangdong, 51016, China
Cancer Hospital of Shantou University Medical College /ID# 242182
Shantou Guangdong, 51504, China
Guangxi Medical University Cancer Center /ID# 231855
Nanning Guangxi, 53002, China
Guizhou Provincial People's Hospital /ID# 243614
Guiyang Guizhou, 55000, China
Affiliated Hospital of Hebei University /ID# 239586
Baoding Hebei, 07100, China
Harbin Medical University Cancer Hospital /ID# 231941
Harbin Heilongjiang, 15008, China
The First affiliated Hospital of Nanyang Medical College /ID# 244652
Nanyang Henan, 47300, China
Henan Provincial People's Hospital /ID# 242187
Zhengzhou Henan, 45000, China
Henan Cancer Hospital /ID# 239577
Zhengzhou Henan, 45000, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 231904
Wuhan Hubei, 43002, China
Hubei Cancer Hospital /ID# 240045
Wuhan Hubei, 43007, China
Hunan Cancer Hospital /ID# 231943
Changsha Hunan, 41000, China
Xiangya Hospital Central South University /ID# 232005
Changsha Hunan, 41000, China
The Affiliated Hospital of Inner Mongolia Medical University /ID# 242179
Huhehaote Inner Mongolia, 01005, China
Nanjing Drum Tower Hospital /ID# 231791
Nanjing Jiangsu, 21000, China
Nantong Tumor Hospital /ID# 232424
Nantong Jiangsu, 22630, China
The First Affiliated Hospital of Nanchang University /ID# 231934
Nanchang Jiangxi, 33000, China
The Second Affiliated Hospital of Nanchang University /ID# 231935
Nanchang Jiangxi, 33000, China
Jilin Cancer Hospital /ID# 244702
Changchun Jilin, 13001, China
The First Hospital of China Medical University /ID# 231924
Shenyang Liaoning, 11000, China
Jinan Central Hospital /ID# 231895
Jinan Shandong, 25001, China
The First Affiliated Hospital of Xi'an Jiaotong University /ID# 232023
Xian Shanxi, 71006, China
West China Hospital, Sichuan University /ID# 233703
Chengdu Sichuan, 61004, China
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 232032
Hangzhou Zhejiang, 31000, China
Zhejiang Cancer hospital /ID# 242476
Hangzhou Zhejiang, 31002, China
Taizhou Hospital, Zhejiang Province /ID# 232021
Taizhou Zhejiang, 31701, China
Sichuan Cancer Hospital /ID# 239707
Chengdu , 61004, China
The First Affiliated Hospital of Dalian Medical University /ID# 239717
Dalian , 11601, China
The Second Hospital of Dalian Medical University /ID# 239755
Dalian , 11602, China
Linyi Cancer Hospital /ID# 239713
Linyi , 27600, China
Ningbo No. 2 Hospital /ID# 242478
Ningbo , 31501, China
Shanghai Chest Hospital /ID# 231897
Shanghai , 20003, China
Tianjin Medical University General Hospital /ID# 231839
Tianjin , 30005, China
Tianjin Medical University Cancer Institute and Hospital /ID# 233176
Tianjin , 30006, China
Tongji Hospital Tongji Medical College of HUST /ID# 239575
Wuhan , 43003, China
Affiliated Hospital Of Guangdong Medical University /ID# 233317
Zhanjiang , 52401, China
Masarykuv onkologicky ustav /ID# 232426
Brno , 656 5, Czechia
Nemocnice AGEL Novy Jicin, a.s. /ID# 232427
Novy Jicin , 741 0, Czechia
Odense University Hospital /ID# 241663
Odense C Syddanmark, 5000, Denmark
Sjællands Universitetshospital, Roskilde /ID# 241842
Roskilde , 4000, Denmark
CHU Bordeaux - Hopital Haut Leveque /ID# 244953
Pessac Gironde, 33604, France
Institut Curie /ID# 240141
Paris CEDEX 05 Ile-de-France, 75248, France
AP-HP - Hopital Tenon /ID# 239179
Paris Ile-de-France, 75020, France
Hopital Arnaud de Villeneuve /ID# 239404
Montpellier Cedex 5 , 34295, France
AP-HP - Hopital Cochin /ID# 239409
Paris , 75014, France
Universitatsklinikum Mannheim /ID# 238331
Mannheim Baden-Wuerttemberg, 68167, Germany
Universitaetsklinikum Jena /ID# 239661
Jena Thueringen, 07747, Germany
Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 239658
Hamburg , 20246, Germany
Haemato-Onkologie Hamburg /ID# 241047
Hamburg , 20251, Germany
Thoraxklinik Heidelberg gGmbH /ID# 239656
Heidelberg , 69126, Germany
Klinikum Kassel /ID# 240142
Kassel , 34125, Germany
General Hospital of Chest Diseases of Athens SOTIRIA /ID# 230824
Athens Attiki, 11527, Greece
Metropolitan Hospital /ID# 239170
Piraeus Attiki, 18547, Greece
The Edith Wolfson Medical Center /ID# 233781
Holon , 58220, Israel
Ziv Medical Center /ID# 238606
Safed , 13100, Israel
Azienda Ospedaliera di Perugia /ID# 238473
Perugia Umbria, 06129, Italy
I.R.C.C.S Istituto Tumori Giovanni Paolo II /ID# 238696
Bari , 70124, Italy
Azienda Socio Sanitaria Territoriale di Cremona /ID# 238698
Cremona , 26100, Italy
Azienda Ospedaliera San Giovanni Addolorata /ID# 238618
Rome , 00184, Italy
ASST Sette Laghi /ID# 238536
Varese , 21100, Italy
NHO Nagoya Medical Center /ID# 246306
Nagoya-shi Aichi, 460-0, Japan
Nagoya University Hospital /ID# 239990
Nagoya-shi Aichi, 46685, Japan
Hirosaki University Hospital /ID# 242377
Hirosaki-shi Aomori, 036-8, Japan
National Cancer Center Hospital East /ID# 233775
Kashiwa-shi Chiba, 277-8, Japan
National Hospital Organization Kyushu Medical Center /ID# 238533
Fukuoka shi Fukuoka, 810-8, Japan
Hospital of the University of Occupational and Environmental Health, Japan /ID# 241191
Kitakyushu-shi Fukuoka, 807-8, Japan
Fukushima Medical University Hospital /ID# 249691
Fukushima-shi Fukushima, 960-1, Japan
Gunma Prefectural Cancer Center /ID# 233723
Ota-shi Gunma, 373-8, Japan
Chugoku Central Hospital /ID# 242970
Fukuyama-shi Hiroshima, 720-0, Japan
Hiroshima University Hospital /ID# 241882
Hiroshima-shi Hiroshima, 734-8, Japan
Hokkaido University Hospital /ID# 241289
Sapporo-shi Hokkaido, 060-8, Japan
Takarazuka City Hospital /ID# 240786
Takarazuka-shi Hyogo, 665-0, Japan
National Hospital Organization Mito Medical Center /ID# 241709
Higashi Ibaraki-gun Ibaraki, 311-3, Japan
Ibaraki Prefectural Central Hospital /ID# 246145
Kasama-shi Ibaraki, 309-1, Japan
Iwate Medical University Hospital /ID# 239027
Shiwa-gun Iwate, 028-3, Japan
Kitasato University Hospital /ID# 239958
Sagamihara-shi Kanagawa, 252-0, Japan
Yokohama City University Medical Center /ID# 246554
Yokohama shi Kanagawa, 232-0, Japan
Kanagawa Cardiovascular and Respiratory Center /ID# 239052
Yokohama-shi Kanagawa, 236-0, Japan
Kumamoto University Hospital /ID# 241039
Kumamoto shi Kumamoto, 86085, Japan
Mie Central Medical Center /ID# 246659
Tsu-shi Mie, 514-1, Japan
Miyagi Cancer Center /ID# 234198
Natori-shi Miyagi, 981-1, Japan
University of Miyazaki Hospital /ID# 242161
Miyazaki-shi Miyazaki, 889-1, Japan
Nagaoka Red Cross Hospital /ID# 240714
Nagaoka-shi Niigata, 940-2, Japan
Kurashiki Central Hospital /ID# 239344
Kurashiki-shi Okayama, 710-8, Japan
Osaka Habikino Medical Center /ID# 239989
Habikino-shi Osaka, 583-8, Japan
Kansai Medical University Hospital /ID# 233476
Hirakata-shi Osaka, 573-1, Japan
Osaka Metropolitan University Hospital /ID# 238895
Osaka-shi Osaka, 545-8, Japan
Kindai University Hospital /ID# 239085
Osakasayama-shi Osaka, 589-8, Japan
Tochigi Cancer Center /ID# 240020
Utsunomiya-shi Tochigi, 320-0, Japan
Juntendo University Hospital /ID# 239932
Bunkyo-ku Tokyo, 113-8, Japan
National Hospital Organization Tokyo Medical Center /ID# 246581
Meguro-ku Tokyo, 152-8, Japan More Info
Site Coordinator
Contact
+81-3-3411-0111
NTT Medical Center Tokyo /ID# 241067
Shinagawa-ku Tokyo, 141-8, Japan
Keio University Hospital /ID# 239506
Shinjuku-ku Tokyo, 160-8, Japan
Toyama University Hospital /ID# 241660
Toyama-shi Toyama, 930-0, Japan
Wakayama Medical University Hospital /ID# 234004
Wakayama-shi Wakayama, 641-8, Japan
Yamagata University Hospital /ID# 240815
Yamagata-shi Yamagata, 990-9, Japan
CHA University Bundang Medical Center /ID# 233318
Seongnam si Gyeonggido, 13496, Korea, Republic of
Ajou University Hospital /ID# 233319
Suwon Gyeonggido, 16499, Korea, Republic of
Gyeongsang National University Hospital /ID# 234244
Jinju Gyeongsangnamdo, 52727, Korea, Republic of
Kangbuk Samsung Hospital /ID# 233711
Seoul Seoul Teugbyeolsi, 03181, Korea, Republic of
SMG-SNU Boramae Medical Center /ID# 233710
Seoul Seoul Teugbyeolsi, 07061, Korea, Republic of
Hospital Civil de Guadalajara Fray Antonio Alcalde /ID# 238488
Guadalajara Jalisco, 44280, Mexico
Centro de Investigacion Clínica Chapultepec SA de CV /ID# 231928
Morelia Michoacan, 58260, Mexico
Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 231880
Monterrey Nuevo Leon, 64460, Mexico
Clinical Research & Oncology Oaxaca /ID# 231883
Oaxaca , 68020, Mexico
Radboud Universitair Medisch Centrum /ID# 233755
Nijmegen Gelderland, 6525 , Netherlands
HagaZiekenhuis /ID# 243693
Den Haag , 2545 , Netherlands
Maastricht Universitair Medisch Centrum /ID# 233932
Maastricht , 6229 , Netherlands
Isala /ID# 238846
Zwolle , 8025 , Netherlands
Instytut Centrum Zdrowia Matki Polki /ID# 239024
Lodz Lodzkie, 93-33, Poland
MRUK-MED I Sp. z o.o. /ID# 239363
Rzeszow Podkarpackie, 35-02, Poland
Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie /ID# 239025
Olsztyn Warminsko-mazurskie, 10-35, Poland
Fundação Champalimaud /ID# 241925
Lisboa , 1400-, Portugal
Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 241572
Porto , 4099-, Portugal
Hospital CUF Porto /ID# 241570
Porto , 4100-, Portugal
IPO Porto FG, EPE /ID# 241569
Porto , 4200-, Portugal
Centro Hospitalar Universitario de Sao Joao, EPE /ID# 241930
Porto , 4200-, Portugal
Oncocenter - Oncologie Clinica Srl /Id# 239103
Timisoara Timis, 30016, Romania
Centrul Medical de Diagnostic si Tratament Ambulator Neomed SRL /ID# 240826
Brasov , 50028, Romania
Sc Oncolab Srl /Id# 239105
Craiova , 20038, Romania
SC RTC Radiology Therapeutic Center SRL /ID# 240744
Otopeni , 07510, Romania
S.C. Sigmedical Services SRL /ID# 239108
Suceava , 72021, Romania
Vychodoslovensky onkologicky ustav, a.s. /ID# 230085
Kosice Kosicky Kraj, 041 9, Slovakia
Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 230084
Banska Bystrica , 975 1, Slovakia
Univerzitna nemocnica Bratislava Nemocnica Ruzinov /ID# 232216
Bratislava , 821 0, Slovakia
Wits Clinical Research Site /ID# 230841
Johannesburg Gauteng, 2193, South Africa
Sandton Oncology Medical Group PTY Ltd /ID# 230843
Johannesburg Gauteng, 2196, South Africa
Dept of Oncology Steve Biko Academic Hospital /ID# 230883
Pretoria Gauteng, 0002, South Africa
UOMi Cancer Center - Clinica Tres Torres /ID# 240584
Barcelona , 08017, Spain
Hospital Universitario de Jaen /ID# 240588
Jaen , 23007, Spain
Hospital Universitario 12 de Octubre /ID# 240176
Madrid , 28041, Spain
Hospital Clinico Universitario de Valencia /ID# 240378
Valencia , 46010, Spain
Sahlgrenska University Hospital /ID# 229943
Gothenburg Vastra Gotalands Lan, 413 4, Sweden
Karolinska University Hospital /ID# 229853
Stockholm , 171 7, Sweden
Changhua Christian Hospital /ID# 238394
Changhua City, Changhua County , 50006, Taiwan
National Taiwan University Hospital - Hsinchu branch /ID# 238393
Hsinchu City , 30059, Taiwan
Hualien Tzu Chi Hospital /ID# 238398
Hualien City , 97002, Taiwan
E-DA Cancer Hospital /ID# 239718
Kaohsiung City , 82445, Taiwan
Chung Shan Medical University Hospital /ID# 238444
Taichung , 40201, Taiwan
National Taiwan University Hospital /ID# 238378
Taipei City , 100, Taiwan
MacKay Memorial Hospital /ID# 238392
Taipei City , 10449, Taiwan
Taipei Medical University Hospital /ID# 238380
Taipei City , 11031, Taiwan
Izmir Ekonomi Universitesi Ozel Medicalpoint Hastanesi /ID# 234209
Karsiyaka Izmir, 35575, Turkey
Adana Acibadem Hospital /ID# 234208
Adana , 01130, Turkey
Ankara City Hospital /ID# 234210
Ankara , 06800, Turkey
Inonu Universitesi Turgut Ozal /ID# 234038
Battalgazi/malatya , 44280, Turkey
Uludag University Medical Faculty /ID# 234205
Bursa , 16059, Turkey
Dicle Universitesi Tip /ID# 234036
Diyarbakir , 21200, Turkey
Bagcilar Medipol Mega Universite Hastanesi /ID# 234211
Istanbul , 34214, Turkey
Ege University Medical Faculty /ID# 234039
Izmir , 35040, Turkey
Baskent Universitesi Adana Dr. Turgut Noyan Uyg. Ve Arast. Merkezi /ID# 238337
Yuregir , 01250, Turkey
Memorial Ankara Hastanesi /ID# 234212
Çankaya , 06520, Turkey
University College London Hospitals NHS Foundation Trust /ID# 249407
London , NW1 2, United Kingdom
The Royal Marsden NHS Foundation Trust /ID# 246974
London , SW3 6, United Kingdom
The Christie Hospital /ID# 243422
Manchester , M20 4, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

698

Study ID:

NCT04928846

Recruitment Status:

Recruiting

Sponsor:


AbbVie

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.